Risk Screening

DNA Risk is a category of gene tests that reports on the risk of certain disorders by analysing associated genetic variations.

DNA Risk assists in screening at-risk individuals, increasing early identification, improving prevention, offering diagnostic insights, and guiding therapy decisions.

HLA-Related Autoimmunity

Autoimmune Diseases and Genetics

Autoimmune diseases occur when the immune system fails to distinguish self from non-self, resulting in a breach of tolerance and the likelihood of inflammation or tissue damage in specific organs or multiple organ systems.

Various genetic and environmental factors have been found to contribute to autoimmune disorders. One of the strongest genetic associations is linked to the MHC region and  their related gene products, the human leukocyte antigens (HLAs). These HLA’s play a pivotal role in the antigen presentation of self and nonself peptides and the regulation of innate and adaptive immune responses.

DNA Risk HLA-Related Autoimmunity

The comprehensive DNA Risk HLA-Related Autoimmunity (HLA test) looks at gene variants related to common autoimmune diseases and provides healthcare practitioners ‘diagnostic insight’ for patients already suffering from an autoimmune disorder, or who are identified as  at risk due to a family history of disease and exposure to environmental risk factors.

The Report

The report presents the HLA alleles and genotype data in a user-friendly manner, followed by a brief description of the relevant autoimmune disorders, insights into environmental contributors, and risk (and protective) HLA alleles and MHC-related gene variants related to the disorders.


  • Alopecia areata (AA)
  • Ankylosing spondylitis (AS)
  • Coeliac disease (CD)
  • Graves’ disease (GD)
  • Hashimoto thyroiditis (HT)
  • IgA nephropathy (IgAN)
  • Lyme borreliosis
  • Multiple sclerosis (MS)
  • Rheumatoid arthritis (RA)
  • Systemic lupus erythematosus  (SLE)
  • Vitiligo
  • Idiopathic membranous nephropathy (IMN)

R2,850.00Add To Cart